clinical trial · NCT06812533
Alleviant ALLAY-HFrEF Study
Alleviant Medical, Inc.·N/A·enrolling by invitation·n = 350
Heart FailureAlleviant ALV1 SystemSham-Control
brief summary
Prospective, multicenter, randomized, sham-controlled, double blind (patient and observer), study designed to evaluate the safety and efficacy of a percutaneously created interatrial shunt using the Alleviant ALV1 System in patients with HFrEF.
started
Mar 10, 2025
primary completion
Dec 1, 2028
completion
Dec 1, 2028
last updated
Apr 21, 2026
official title
Safety and Efficacy of the Alleviant No-Implant Interatrial Shunt in Patients With Heart Failure and Reduced Ejection Fraction
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol